Chemotherapy of leishmaniasis : present challenges

Chemotherapy of leishmaniasis : present challenges

Silvia R. B. Uliana, Cristiana T. Trinconi, Adriano C. Coelho

ARTIGO

Inglês

Agradecimentos: We wish to thank Dr. Jeffrey J. Shaw for support and countless fruitful discussions. We thank Jenicer Yokoyama-Yasunaka for the continuous support. This work was supported by the São Paulo Research Foundation (FAPESP) (grant number 2015/09080-2) ; Conselh

Cutaneous and visceral leishmaniasis are amongst the most devastating infectious diseases of our time, affecting millions of people worldwide. The treatment of these serious diseases rely on a few chemotherapeutic agents, most of which are of parenteral u

CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ

FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP

fechado

Chemotherapy of leishmaniasis : present challenges

Silvia R. B. Uliana, Cristiana T. Trinconi, Adriano C. Coelho


										

Chemotherapy of leishmaniasis : present challenges

Silvia R. B. Uliana, Cristiana T. Trinconi, Adriano C. Coelho

    Fontes

    Parasitology

    Vol. 145, no. 4 (Apr., 2018), p. 464-480